Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.

Mayo Clinic Proceedings
Ayman El-MenyarDavid R Holmes

Abstract

Renal insufficiency (RI) has been shown to be associated with increased major adverse cardiovascular events after percutaneous coronary intervention. We reviewed the impact of RI on the pathogenesis of coronary artery disease and outcomes after percutaneous coronary intervention in the form of drug-eluting stent (DES) implantation in these high-risk patients. We searched the English-language literature indexed in MEDLINE, Scopus, and EBSCO Host research databases from 1990 through January 2009, using as search terms coronary revascularization, drug-eluting stent, and renal insufficiency. Studies that assessed DES implantation in patients with various degrees of RI were selected for review. Most of the available data were extracted from observational studies, and data from randomized trials formed the basis of a post hoc analysis. The outcomes after coronary revascularization were less favorable in patients with RI than in those with normal renal function. In patients with RI, DES implantation yielded better outcomes than did use of bare-metal stents. Randomized trials are needed to define optimal treatment of these high-risk patients with coronary artery disease.

References

Jul 1, 1994·Journal of the American Society of Nephrology : JASN·M P GawazS K Mujais
Jan 1, 1996·Japanese Circulation Journal·M TsutsuiS Okamatsu
Jan 17, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Luis GrubergMartin B Leon
Mar 30, 2002·Journal of the American College of Cardiology·Patricia J M BestPeter B Berger
Aug 21, 2002·Circulation·Jassim Al SuwaidiUNKNOWN PARAGON-A Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organi
Oct 2, 2002·Annals of Internal Medicine·R Scott WrightAllan S Jaffe
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Oct 7, 2004·Journal of the American College of Cardiology·Rajiv GuptaBarry F Uretsky
Jan 13, 2005·JAMA : the Journal of the American Medical Association·Adnan KastratiUNKNOWN ISAR-DESIRE Study Investigators
May 5, 2005·JAMA : the Journal of the American Medical Association·Ioannis IakovouAntonio Colombo
Dec 22, 2005·American Heart Journal·Daniel J BlackmanVladimir Dzavik
Mar 15, 2006·Kidney & Blood Pressure Research·Wolfgang BockschRainer Dietz
May 16, 2006·Journal of the American College of Cardiology·Jun-ichi KotaniSeiki Nagata
Aug 9, 2006·Seminars in Dialysis·Dinkar Kaw, Deepak Malhotra
Sep 21, 2006·JAMA : the Journal of the American Medical Association·Steven G CocaChirag R Parikh
Oct 20, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andrzej KraśniakWładysław Sulowicz
Nov 15, 2006·Circulation·Nehiro KuriyamaIssei Komuro
Dec 28, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Gaku NakazawaKazuhiro Hara
Jan 16, 2007·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·John McB HodgsonUNKNOWN Society for Cardiovascular Angiography and Interventions
Aug 7, 2007·Journal of the American College of Cardiology·Jacques MachecourtUNKNOWN EVASTENT Investigators
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Mark E Williams
Sep 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Naoki IshioIssei Komuro
Nov 30, 2007·American Journal of Nephrology·Michel ChoncholNancy R Kressin
Dec 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Toru AoyamaToyoaki Murohara

❮ Previous
Next ❯

Citations

Mar 26, 2016·Journal of the American College of Cardiology·Anthony A Bavry, Ki Park
Apr 4, 2013·Heart, Lung & Circulation·Salil V DeoSoon J Park
Aug 6, 2016·Journal of the American Society of Nephrology : JASN·Gautam R Shroff, Charles A Herzog
Nov 10, 2010·Seminars in Cardiothoracic and Vascular Anesthesia·Tzong-Huei Chen, Robina Matyal
Dec 13, 2018·Journal of Cardiovascular Medicine·Joseph T KnapperJames D Flaherty
Feb 9, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Yung-Tai ChenChia-Jen Shih
Dec 7, 2013·International Heart Journal·Yoshiaki KawaseKatsumi Ueno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
Gaku NakazawaKazuhiro Hara
Expert Review of Cardiovascular Therapy
Ayman El-Menyar, Jassim Al Suwaidi
© 2021 Meta ULC. All rights reserved